SCHEMBL20071974

SCHEMBL20071974

Cc1ccccc1-c1ccc2c3ccccc3c3ccccc3c2c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ CYP1A2 P05177 4/20 0.49
▸ CYP3A4 P08684 4/20 0.49
▸ TSHR P16473 4/20 0.49
▸ CLK4 Q9HAZ1 4/20 0.49
▸ CYP2D6 P10635 3/20 0.49
▸ CYP2C19 P33261 3/20 0.49
▸ ALDH1A1 P00352 2/20 0.49
▸ MAPK1 P28482 2/20 0.49
▸ CYP2C9 P11712 1/20 0.49
▸ PRMT5 O14744 1/20 0.48
▸ WDR77 Q9BQA1 1/20 0.48
▸ MCL1 Q07820 1/20 0.47
▸ NMT2 O60551 1/20 0.46
▸ NMT1 P30419 1/20 0.46
▸ TRPA1 O75762 1/20 0.46
▸ CTSD P07339 1/20 0.46
▸ BACE1 P56817 1/20 0.46
▸ HTR7 P34969 2/20 0.44
▸ CA12 O43570 2/20 0.44
▸ CA9 Q16790 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20407282 0.92 CA12 (0.46) CYP1A2CYP3A4TSHRCLK4CYP2D6
SCHEMBL17536903 0.87 KDM4E (0.45) CYP1A2CYP3A4TSHRCLK4CYP2D6
SCHEMBL20407139 0.87 MCL1 (0.41) CYP1A2CYP3A4TSHRCLK4CYP2D6
SCHEMBL4262930 0.83 CYP1A2 (0.46) CYP1A2CYP3A4TSHRCLK4CYP2D6
SCHEMBL28609424 0.82 TSHR (0.39) CYP1A2CYP3A4TSHRCLK4CYP2D6
SCHEMBL16135203 0.82 CYP1A2 (0.38) CYP1A2CYP3A4TSHRCLK4CYP2D6
SCHEMBL16743919 0.81 MCL1 (0.44) CYP1A2CYP3A4TSHRCLK4CYP2D6
SCHEMBL17073387 0.81 TSHR (0.37) CYP1A2CYP3A4TSHRCLK4CYP2D6
SCHEMBL19754685 0.81 L3MBTL1 (0.46) CYP1A2CYP3A4TSHRCLK4CYP2D6
SCHEMBL17536915 0.80 TNKS2 (0.44) CYP1A2CYP3A4CYP2D6CYP2C19CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10608185-B2 Organic electroluminescent materials and devices UNIVERAL DISPLAY CORPORATION (US) 2020-03-31 — — US disclosed
US-20180108844-A1 Organic Electroluminescent Materials and Devices UNIVERSAL DISPLAY CORPORATION 2018-04-19 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180108844-A1 Organic Electroluminescent Materials and Devices SLCO4C1, SLCO2A1, SLCO2B1 CYP1A2 1141/4885CYP3A4 668/4885TSHR 3944/4885
US-10608185-B2 Organic electroluminescent materials and devices SLCO4C1, SLCO2A1, SLCO2B1 CYP1A2 1141/4885CYP3A4 668/4885TSHR 3944/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback